聯通與騰訊合資公司雲宙時代科技成立 提供CDN及邊緣計算服務
據內媒報道,中國聯通(00762.HK)表示,日前與騰訊(00700.HK)(TCEHY.US)進一步深化合作,共同出資設立的雲宙時代科技有限公司正式在京成立。
於2022年10月,國家市場監督管理總局公布聯通創投與騰訊產投新設合營企業案獲批。隨後,中國聯通公布,基於公司全面挺進數字經濟的戰略需要,下屬子公司聯通創投擬與騰訊創投新設合營企業,主要從事內容分發網絡(CDN)和邊緣計算業務。(ta/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.